Sentence: These results provide compelling preclinical rationale indicating lapatinib to be a potentially efficacious chemotherapeutic combination partner for irinotecan in the treatment of gastrointestinal carcinomas .
Drug combination annotation:
[{'class': 'POS', 'spans': ['lapatinib', 'irinotecan'], 'is_context_needed': False}]